Mechanism of the anti-hypertensive property of the naturally occurring phenolic, malabaricone C in DOCA-salt rats
- 4 November 2015
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 50 (1) , 111-121
Abstract
In this study, we studied whether chronic oral administration of the natural antioxidant, malabaricone C (mal C) can reduce blood pressure (BP) and attenuate cardio-vascular remodeling in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. The dose of mal C for its anti-hypertensive action was optimized by measuring the systolic BP (SBP). DOCA-salt rats showed very high SBP, associated with organ hypertrophy, collagen depositions, and inflammatory infiltrations in cardiac and aortic sections, reduced plasma total antioxidant status and NO level, and increased levels of TBARS, PGI2 as well as vasoconstrictors (AVP, Big ET, and ET-1). DOCA-salt also reduced smooth muscle- and endothelium-dependent vascular relaxation in rats. Mal C reversed all these changes of the DOCA-salt rats and improved their vascular reactivity. Mal C exerts anti-hypertensive property in DOCA-salt rats by reducing oxidative stress and organ hypertrophy, and improving endothelial and vascular functions. Given that mal C has appreciable natural abundance and is non-toxic to rodents, further studies would help in establishing its medicinal potential against hypertension.Keywords
This publication has 43 references indexed in Scilit:
- Effect of atenolol and enalapril treatment on oxidative stress parameters in patients with essential hypertensionInternational Journal of Basic & Clinical Pharmacology, 2013
- Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertensionNutrition & Metabolism, 2011
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Adenosine A2Areceptors play a role in the pathogenesis of hepatic cirrhosisBritish Journal of Pharmacology, 2006
- Novel therapeutic strategies for reducing arterial stiffnessBritish Journal of Pharmacology, 2006
- Improved cardiovascular function with aminoguanidine in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2006
- Oxidative Stress and Antioxidant Treatment in Hypertension and the Associated Renal DamageAmerican Journal of Nephrology, 2005
- Endothelin-1 Increases Vascular Superoxide via Endothelin A –NADPH Oxidase Pathway in Low-Renin HypertensionCirculation, 2003
- Effect of reactive oxygen species on endothelin-1 production by human mesangial cellsKidney International, 1996
- Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.Hypertension, 1993